von Wasielewski R - Search Results

1

Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer.

Gaedcke J, Traub F, Milde S, Wilkens L, Stan A, Ostertag H, Christgen M, von Wasielewski R, Kreipe HH. Gaedcke J, et al. Among authors: von wasielewski r. Mod Pathol. 2007 Aug;20(8):864-70. doi: 10.1038/modpathol.3800830. Epub 2007 Jun 1. Mod Pathol. 2007. PMID: 17541441 Free article.

2

[Tissue-based markers of prognosis in breast cancer].

Kreipe H, von Wasielewski R. Kreipe H, et al. Among authors: von wasielewski r. Verh Dtsch Ges Pathol. 2005;89:52-8. Verh Dtsch Ges Pathol. 2005. PMID: 18035673 German.

3

Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial.

Mengel M, von Wasielewski R, Wiese B, Rüdiger T, Müller-Hermelink HK, Kreipe H. Mengel M, et al. Among authors: von wasielewski r. J Pathol. 2002 Nov;198(3):292-9. doi: 10.1002/path.1218. J Pathol. 2002. PMID: 12375261 Clinical Trial.

4

Prognostic impact of Skp2 and p27 in human breast cancer.

Traub F, Mengel M, Lück HJ, Kreipe HH, von Wasielewski R. Traub F, et al. Among authors: von wasielewski r. Breast Cancer Res Treat. 2006 Sep;99(2):185-91. doi: 10.1007/s10549-006-9202-3. Epub 2006 Apr 25. Breast Cancer Res Treat. 2006. PMID: 16636894

5

Legumain expression as a prognostic factor in breast cancer patients.

Gawenda J, Traub F, Lück HJ, Kreipe H, von Wasielewski R. Gawenda J, et al. Among authors: von wasielewski r. Breast Cancer Res Treat. 2007 Mar;102(1):1-6. doi: 10.1007/s10549-006-9311-z. Epub 2006 Sep 21. Breast Cancer Res Treat. 2007. PMID: 17028987

6

Beyond typing and grading: target analysis in individualized therapy as a new challenge for tumour pathology.

Kreipe HH, von Wasielewski R. Kreipe HH, et al. Among authors: von wasielewski r. Recent Results Cancer Res. 2007;176:3-6. doi: 10.1007/978-3-540-46091-6_1. Recent Results Cancer Res. 2007. PMID: 17607911

7

Light-chain mRNA in lymphocyte-predominant and mixed-cellularity Hodgkin's disease.

von Wasielewski R, Wilkens L, Nolte M, Werner M, Georgii A. von Wasielewski R, et al. Mod Pathol. 1996 Mar;9(3):334-8. Mod Pathol. 1996. PMID: 8685237

8

Applications of single-color and double-color oligonucleotide primed in situ labeling in cytology.

Werner M, Nasarek A, Tchinda J, von Wasielewski R, Komminoth P, Wilkens L. Werner M, et al. Among authors: von wasielewski r. Mod Pathol. 1997 Nov;10(11):1164-71. Mod Pathol. 1997. PMID: 9388069

9

[Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker].

von Wasielewski R, Klöpper K, Lück HJ, Kreipe H. von Wasielewski R, et al. Pathologe. 2006 Sep;27(5):337-45. doi: 10.1007/s00292-006-0855-9. Pathologe. 2006. PMID: 16896675 German.

10

[Interlaboratory trials for quality assurance of breast cancer biomarkers in Germany].

Krusche CA, von Wasielewski R, Rüschoff J, Fisseler-Eckhoff A, Kreipe HH. Krusche CA, et al. Among authors: von wasielewski r. Pathologe. 2008 Jul;29(4):315-20. doi: 10.1007/s00292-008-1004-4. Pathologe. 2008. PMID: 18504581 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page